8-K: USANA Health Sciences Reports Mixed Q2 2025 Results, Reaffirms Full-Year Outlook Amid Strategic Rollout

USANA Health Sciences announced its second quarter 2025 financial results, reporting 11% year-over-year net sales growth but a decline in net earnings and active direct selling customers, while reiterating its full-year fiscal 2025 outlook.

Summary

• Consolidated net sales for Q2 2025 increased 11% year-over-year to $236 million, up from $213 million in Q2 2024.
• Net earnings decreased 7% year-over-year to $9.7 million in Q2 2025, down from $10.4 million in Q2 2024.
• Diluted EPS was $0.52, a 4% decrease from $0.54 in the prior year quarter.
• Adjusted diluted EPS rose 36% year-over-year to $0.74, compared to $0.54 in Q2 2024.
• Adjusted EBITDA increased 13% year-over-year to $30 million, up from $27 million.
• Direct selling Active Customers declined 11% year-over-year to 418,000 from 468,000.
• Hiya, the direct-to-consumer business, reported $34 million in net sales and 200,400 Active Monthly Subscribers.
• Generated $13 million in operating cash flow during the quarter and ended with $151 million in cash and cash equivalents, with zero debt after repaying a $23 million credit facility draw.
• Repurchased 528,000 shares for $15 million, with approximately $34 million remaining under the current share repurchase authorization.
• Inventories increased by 19% to $86 million compared to the fiscal 2024 year-end balance, partly due to managing tariff exposure and supporting growth strategies for Hiya and Rise.
• Gross margin decreased by 240 basis points to 78.7% of net sales, primarily due to the inclusion of Hiya which has lower gross margins.
• Brand Partner Incentives decreased by 560 basis points to 36.9% of net sales on a consolidated basis, largely due to Hiya not having Brand Partner Incentives.
• Selling, General and Administrative expenses increased by 450 basis points to 34.7% as a percentage of net sales, reflecting the inclusion of Hiya and a loss of leverage on lower direct selling net sales.
• The year-to-date effective tax rate increased to 44.5% from 43.0% in the comparable period of 2024, attributed to changes in the market mix of pre-tax income.
• Reiterated fiscal year 2025 outlook: consolidated net sales of $920 million to $1.0 billion, net earnings of $29 million to $41 million, diluted EPS of $1.50 to $2.20, adjusted diluted EPS of $2.35 to $3.00, and adjusted EBITDA of $107 million to $123 million.
• Fiscal 2025 is a 53-week year, including one additional week of sales compared to fiscal 2024.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While net earnings and diluted EPS declined, and active direct selling customers decreased, the company achieved strong net sales growth, significant adjusted EPS and EBITDA growth, and maintained a strong balance sheet with zero debt. The performance of the Hiya direct-to-consumer business is a notable positive. The reiteration of the full-year outlook, despite a 'fluid operating environment,' suggests management confidence in their strategic initiatives, which are actively being rolled out to address the challenges in the core direct selling business. The decline in active customers and GAAP profitability are concerns, but the strategic response and Hiya's growth provide a counterbalance.

Positives

• Consolidated net sales grew 11% year-over-year to $236 million.
• Adjusted diluted EPS increased significantly by 36% year-over-year to $0.74.
• Adjusted EBITDA rose 13% year-over-year to $30 million.
• Hiya, the direct-to-consumer business, demonstrated strong year-over-year top-line growth and improved profitability, with $34 million in net sales and 200,400 active monthly subscribers.
• The company generated $13 million in operating cash flow and ended the quarter debt-free with $151 million in cash and cash equivalents after repaying a $23 million credit facility draw.
• Hiya launched a new partnership with Disney for special edition branded Multivitamin packs and is expanding its product offering with Kids Daily Hydration and Kids Daily Greens + Superfoods.
• Rise Bar, a healthy-foods business acquired in 2022, reported strong double-digit top-line growth in the second quarter.
• The company is executing a comprehensive commercial strategy for its direct sales business, including enhanced incentive offerings, new Brand Partner terminology, and improved business support tools.
• Reiterated full-year fiscal 2025 outlook, indicating confidence in achieving projected consolidated net sales growth of 8% to 17%.

Negatives

• Net earnings decreased 7% year-over-year to $9.7 million.
• Diluted EPS declined 4% year-over-year to $0.52.
• Direct selling Active Customers decreased 11% year-over-year to 418,000.
• All direct selling regions experienced year-over-year declines in net sales and active customers, including Greater China (-2% net sales, -8% active customers), North Asia (-13% net sales, -12% active customers), Southeast Asia Pacific (-7% net sales, -12% active customers), and Americas and Europe (-8% net sales, -17% active customers).
• Gross margin decreased by 240 basis points to 78.7% of net sales, primarily due to the lower gross margins of the Hiya business.
• Selling, General and Administrative expenses increased by 450 basis points as a percentage of net sales, partly due to the inclusion of Hiya and a loss of leverage on lower direct selling net sales.
• The year-to-date effective tax rate increased to 44.5% from 43.0% in the prior year, impacting profitability.
• Anticipated short-term increase in promotional costs in Q3 due to the global launch of the updated direct sales compensation plan.
• Anticipated increased spending on customer acquisition sequentially in the Hiya business during Q3, reflecting normal seasonal activity.

Risks

• Risks relating to global economic conditions generally, including continued inflationary pressure and negative impact on operating costs, consumer demand, and consumer behavior.
• Reliance upon the network of independent Brand Partners and the risk that changes to the compensation plan may not produce desired results or could harm the business.
• Risks associated with the launch of new products or reformulated existing products.
• Risks related to governmental regulation of products, manufacturing, and the direct selling business model in the United States, China, and other key markets.
• Potential negative effects of deteriorating foreign and/or trade relations, including adverse impact from tariffs, trade policies, or international disputes.
• Potential negative effects from geopolitical relations and conflicts around the world, including the Russia-Ukraine conflict and the conflict in Israel.
• Compliance with data privacy and security laws and regulations globally.
• Potential negative effects of material breaches or failures of information technology systems.
• Adverse publicity risks globally.
• Risks associated with early stage operations in India and future international expansion.
• Uncertainty relating to the fluctuation in U.S. and other international currencies.
• The potential for a resurgence of COVID-19, or another pandemic, and any related impact on consumer health, economies, and discretionary spending.
• Risk that the Hiya acquisition disrupts current plans and operations, diverts management attention, or impacts the ability to retain key personnel.
• The ability to realize the benefits of the Hiya acquisition, including efficiencies and cost synergies, and to successfully integrate Hiya's business.
• The amount of costs, fees, expenses, and charges related to the Hiya acquisition.

Future Outlook

The company reiterated its fiscal year 2025 outlook, anticipating consolidated net sales between $920 million and $1.0 billion, net earnings of $29 million to $41 million, diluted EPS of $1.50 to $2.20, adjusted diluted EPS of $2.35 to $3.00, and adjusted EBITDA of $107 million to $123 million. This outlook reflects expected net sales from the direct selling business of $775 million to $840 million and from Hiya of $145 million to $160 million (representing 29% to 42% year-over-year growth). The effective tax rate is projected to be 44.0% to 45.0%. The wider than normal range for the outlook reflects the fluid operating environment and changes to the direct sales incentive offering. Increased promotional costs are anticipated in Q3 for the global launch of the updated direct sales compensation plan, along with increased customer acquisition spending for Hiya, reflecting normal seasonal activity.

Management Comments

• "Our business performed in line with expectations, and we are maintaining our fiscal 2025 outlook."
• "We continue to execute our comprehensive commercial strategy for our direct sales business, which represents over two years of research, analysis, and planning."
• "Hiya, our direct-to-consumer business, had another strong quarter as year-over-year top line growth remained strong with improved profitability."
• "Second quarter operating results for both our core direct sales business and for Hiya were in line with internal expectations as we continued to execute our overall growth strategy."
• "During the quarter, we also repaid the $23 million draw on our credit facility deployed in the Hiya transaction and are again debt-free."
• "The wider than normal range reflects the fluid operating environment and changes to our direct sales incentive offering."
• "During the third quarter we anticipate a short-term increase in promotional costs in conjunction with the global launch of our enhanced direct sales compensation plan."
• "Additionally, we anticipate increased spending on customer acquisition sequentially in our Hiya business during the third quarter, which reflects normal seasonal activity."
• "We remain focused on executing our commercial strategy as we aim to grow customer counts, increase engagement and deliver long-term sustainable growth. We are committed to growing our consolidated business and are confident that the successful execution of our strategies will position us to deliver sustainable long-term growth."

Industry Context

The direct selling segment continues to face a challenging environment to attract new customers, particularly in the Americas and Europe, and is impacted by local economic conditions affecting consumer sentiment in markets like South Korea. In contrast, the direct-to-consumer children's health and wellness market, represented by Hiya, shows strong growth potential and is expanding through new partnerships and product diversification. The company's strategic shift towards modernizing its direct sales model and leveraging its in-house manufacturing capabilities reflects broader industry trends of adapting to changing consumer behaviors and supply chain dynamics.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders: Mixed financial results with sales growth but declining GAAP earnings. The share repurchase program and debt-free status are positive for shareholder value. The reiterated outlook provides stability, but the decline in active customers in the core business could be a long-term concern if not reversed by strategic initiatives.
• Brand Partners (Direct Sales Force): The company is rolling out enhanced incentive offerings, simplifying the direct sales model, and providing improved personalized business support, which aims to provide a more compelling opportunity to drive sustainable sales and active customer growth. This could improve their earning potential and business ease.
• Customers: New and enhanced health products are planned, and Hiya is expanding its product offering and partnerships (e.g., Disney), potentially offering more choices and value.
• Employees: The reorganization of the commercial team involved repurposing activities and individuals, leading to shifts in expense recognition, which could indicate internal restructuring.
• Suppliers: Increased inventory levels suggest continued demand for raw materials and products, potentially benefiting suppliers. Efforts to seek alternative sourcing relationships to manage tariff exposure could shift supplier relationships.

Next Steps

• Continue the roll-out of the comprehensive commercial strategy for the direct sales business throughout Q3 2025.
• Make other important announcements to advance the commercial strategy at the global convention in August 2025 and throughout Q3 2025.
• Simplify the direct sales model.
• Introduce additional enhanced sales incentives.
• Provide improved personalized business support for Brand Partners.
• Implement refreshed USANA brand messaging.
• Launch several new and enhanced health products in the second half of 2025 and 2026.
• Host a global convention in Salt Lake City in August 2025 for Brand Partners, including training on new sales incentives, product, and brand enhancements.
• Continue to execute strategies to further expand Hiya's product offering, distribution channels, and geographic footprint.
• Capitalize upon identified synergies and operational efficiencies across logistics and manufacturing for Hiya.
• Increase promotional costs in Q3 2025 in conjunction with the global launch of the updated direct sales compensation plan.
• Increase spending on customer acquisition sequentially in the Hiya business during Q3 2025.

Key Dates

Recommendation

The filing presents a mixed bag of results. While USANA achieved solid top-line growth and strong adjusted profitability, the decline in GAAP net earnings and, more critically, the 11% year-over-year drop in direct selling active customers are significant concerns for a direct sales model. The company is actively implementing a comprehensive commercial strategy, including enhanced incentives and a simplified model, which is a positive step towards addressing these challenges. The Hiya acquisition continues to perform well and contributes to overall growth. However, the success of the new direct sales strategy is yet to be fully realized, and the 'fluid operating environment' suggests ongoing headwinds. Given the current decline in the core customer base balanced by strategic initiatives and Hiya's growth, a 'hold' recommendation is appropriate. Investors should monitor the effectiveness of the new commercial strategy in reversing customer declines and improving GAAP profitability in subsequent quarters before considering a stronger position.

Keywords

Nutritional Supplements, Direct Selling, Multi-level Marketing, Health and Wellness, Financial Results, Earnings Report, Consumer Goods, Hiya Health, Brand Partners, Global Sales, Share Repurchase, Strategic Initiatives, Q2 2025, USANA